Perioperative Evaluation and Treatment in Pediatrics

86
06/06/22 1 Perioperative Management of the Pediatric Patient Moises Auron MD, FAAP FACP Assistant Professor of Medicine Hospital Medicine

description

Review and presentation of the current literature on perioperative assessment and management in the Pediatric population with an emphasis in the medically complex Pediatric patient.

Transcript of Perioperative Evaluation and Treatment in Pediatrics

Page 1: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 1

Perioperative Management of the Pediatric Patient

Moises Auron MD, FAAP FACP

Assistant Professor of Medicine

Hospital Medicine

Page 2: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 2

Disclosure Statement

• The author has no relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in this educational activity.

Page 3: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 3

Outline• Goals of pre-operative assessment• Anesthesia associated risk• General pre-operative management• Pulmonary issues• Cardiac issues • Brief review of cardiac risk assessment and management in non-

cardiac surgery – adult guidelines• Morbid obesity• Neurologic issues and Epilepsy• Musculoskeletal and craniofacial issues• SCD• Perioperative Management of Diabetes• Perioperative VTE Prophylaxis• Psychological preparation for surgery

Page 4: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 4

Goal of preoperative assessment

• Detection of unrecognized conditions that increase the risk of surgery.

• Optimize the patient’s current medical problems and anticipate potential complications. – Anticipate pulmonary edema post-T/A– OSA– Monitor for atlantoaxial instability (Down’s)

Page 5: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 5

Model of Plane Flight

P A T I E N TP A T I E N TSurgeon = Pilot Anesthesia = Co-Pilot

Michota F. Jaffer A. CCJM. 2006

Page 6: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 6Anesth Analg 2004;99:1058-69.

Page 7: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 7

What is different in Pediatrics

• Age - > 70 y/o – robust indicator for post-operative pulmonary morbidity

• Exercise capacity – unclear in infants and toddlers– Climb 1 flight of stairs = 4 mets = low CV risk

• Medication use

• Risk for venous thromboembolism

Page 8: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 8

General perioperative concerns in Pediatrics.

• Congenital heart disease – Hypoxia, arrhythmias, and cardiovascular instability paradoxical

air emboli

• Prematurity – Postoperative apnea

• Gastrointestinal reflux – Aspiration pneumonia

• URI – Laryngospasm, bronchospasm, hypoxia, and pneumonia

• Craniofacial abnormality – Difficult airway

Childs Nerv Syst (2006) 22:834–843

Page 9: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 9

Patient related risk Procedure related risk

Anesthetic-related risk Provider-related risk

Perioperative risk

Michota F, Frost S; Med Clin N Am 2002.

Page 10: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 10

Role of the surgeon

• Surgeons are typically consulted for evaluation and treatment of:– healthy child who is undergoing elective

surgery– the chronically ill child who requires surgery– the acutely ill on injured child who requires

emergent surgery.

Pediatrics 1996;98;502-508.

Page 11: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 11

Role of the anesthesiologist

• Anesthesia may begin outside the OR with the administration of preoperative medication.

• Patient follow up until D/C from the PACU – Except if regional analgesia or spinal block

are used

Pediatrics 1996;98;502-508.

Page 12: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 12

Anesthesia-associated risk• Risk for adverse events continues to be higher in

infants and young children • Overall mortality rate was 0.9/10,000 anesthetics • Incidence of cardiac arrest of 1.7/10,000

– Adult (1.4/10,000). – Children < 12 y/o (4.7/10,000) – 3x– Complications of airway management (laryngospasm,

difficult intubation, and pulmonary aspiration of gastric contents)

– Halothane (hypotension, arrhythmia, or both).

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43.

Page 13: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 13

Anesthesia-associated risk

• Greater risk occurs in infants < 4 wk old. – More likely to be having major surgery (intrathoracic or

intraabdominal) – Have more serious underlying disease– Increased percentage are (ASA) physical status 3–5. – Reduction in respiratory-related events compared with

previous studies was believed to be because of improved detection of impending respiratory events caused by oximetry and capnography.

– Associated with emergency surgery, halothane or sevoflurane, caudal injection of bupivacaine/epinephrine

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 14: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 14

ASA Classification

• Class 1 A normally healthy patient• Class 2 A patient with mild systemic disease• Class 3 A patient with severe systemic

disease that is not incapacitating• Class 4 A patient with an incapacitating

systemic disease that is a constant threat to life

• Class 5 A moribund patient who is not expected to survive for 24 h with or without operation

Anesthesiology 1963; 24: 111.Pediatric Anesthesia 2007 17: 216–222.

Page 15: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 15

ASA Classification in Pediatrics

Pediatric Anesthesia 2007 17: 216–222.

Page 16: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 16

Preoperative Evaluation

• HPI

• PMH– Croup– OSA– Cervical instability (Down’s)

• Medications – NSAID’s

• Allergies – Latex (spina bifida)

Pediatrics 1996;98;502-508.

Page 17: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 17

Pre-operative evaluation

• Family history – Anesthetic-related complications

• malignant hyperthermia • prolonged paralysis after anesthesia

(pseudocholinesterase deficiency)

– Bleeding disorders– Muscular dystrophy– Drug use (aminoglycosides)

Pediatrics 1996;98;502-508.

Page 18: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 18

Pre-operative evaluation

• Last meal intake

• Physical examination– Hydration status

Pediatrics 1996;98;502-508.

Page 19: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 19

Ancillary testing

• Hb - when significant anemia (<9 g/L) is suspected– (eg, infants, growing premature infants, and

patients with chronic illnesses) – to establish a reference point in anticipation to

significant blood loss (Orthopedic surgery).

• Pregnancy testing

Pediatrics 1996;98;502-508.

Page 20: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 20

Ancillary testing• Coagulation profile

– history or medical condition suggests a possible hemostatic defect:• large bruises and hematomas• simultaneous bruising on several parts of the body• Hematochezia• frequent and prolonged epistaxis• Hemarthrosis• unusual bleeding after minor trauma (including dental extraction)

– Recent ingestion of aspirin or NSAIDS. – Cardiopulmonary bypass – induction of hemostatic disorder by platelet

activation and consumption– Tonsillectomy; airway surgery– Neurosurgical patients (craniotomy)

• Minor surgery and a negative history: no tests are suggested.

Pediatrics 1996;98;502-508.

Page 21: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 21

Fasting guidelines

• 8-6-4-2

• 8 hours solids

• 6 hours formula

• 4 hours breast milk

• 2 hours clear liquids

Anesthesiology. 1999;90(3):896-905

Acta Anaesthesiol Scand 2005;49:1041-1047.

Best Practice & Research Clinical Anaesthesiology. 2006; 20(3):471-81.

Page 22: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 22

Pulmonary issues

• URI – defer surgery until symptoms resolve– Increased risk of bronchospasm– Decreased 50% with use of Laryngeal Mask Airway

• Asthma – should be optimally controlled– Continue bronchodilators and oral meds in AM of

surgery– Delay surgery 6 wk after asthma attack (FEV1

remains low x 6 wk). – Prednisone 1 mg/kg 24-48 h pre-operatively and in

the AM of surgery.

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Pediatrics 1996;98;502-508.

Page 23: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 23

Pulmonary issues

• FEV1/FVC -useful predictors of the need for postoperative mechanical ventilation among patients at risk (eg, cystic fibrosis, severe scoliosis, or kyphoscoliosis).

• Adults - increased incidence of need for postoperative mechanical ventilation:– FEV1/FVC < 50%– FEV1 < 35% predicted– Absolute FVC < 25 mL/kg

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 24: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 24

Pulmonary issues

• Cystic fibrosis – continue pulmonary toilet, optimize nutritional status, continue home meds (inhaled and systemic antibiotics, dornase alpha, acetylcysteine, bronchodilators).

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 25: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 25

Pulmonary issues

• Obstructive Sleep apnea – Adenotonsillar hyperthrophy, obesity, Prader Willi,

Down’s– Pulmonary HTN and Cor Pulmonale– Greatest risk of post-op upper airway obstruction

• Tissue edema• Secretions• Sedation (narcotics)• Pulmonary edema

– Best practice: 24 h observation in PICU

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 26: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 26

Pulmonary issues

• Prematurity and apnea– Decreased risk with spinal anesthesia– Preoperative use of caffeine– Admit and monitor with SpO2.

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 27: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 27

Former Preterm Risk for Postoperative apnea

• Bronchopulmonary dysplasia• Chronic hypoxemia and hypercarbia• Tracheomalacia; bronchomalacia• Pulmonary hypertension; Cor pulmonale• Risk factors:

– Anemia (Hct <30%)– Apnea at home – Gestational age (<30 wk)– LBW (< 1.5 kg)– Lower weight at time of surgery– Complicated NICU course

Murphy JJ. J Pediatr Surg. 2008. May;43(5):865-8

Page 28: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 28

Post-operative atelectasis

• Impaired surfactant

• Increased gas reabsorption

• Extrinsic compression

• Favored by:• General anesthesia• Recumbent position – decrease FRC 0.5 – 1.0 L

• High FiO2

• Surgery close to the diaphragm

Anesthesiology 2005; 102:838–54

Curr Opin Anaesthesiol. 2007;20:37–42.

Page 29: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 29

Post-operative atelectasis

Anesthesiology 2005; 102:838–54

Curr Opin Anaesthesiol. 2007;20:37–42.

Page 30: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 30

Age and atelectasis

• Children age 1–3 years atelectasis develop more readily than in adults.

• Increased thoracic rib cage compliance less outward recoil of the chest wall less distending force on the lung.

• High closing volume (the lung volume at which small airways begin to close)

Anesthesiology 2005; 102:838–54

Curr Opin Anaesthesiol. 2007;20:37–42.

Page 31: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 31

Physiologic consequences of atelectasis

• Decreased compliance• Hypoxemia• Increased pulmonary vascular resistance• Lung injury (repetitive opening and closure of small airways).

Anesthesiology 2005; 102:838–54

Curr Opin Anaesthesiol. 2007;20:37–42.

Page 32: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 32Chest 1995; 107:81-84

N = 100 postop cardiac surgery patients

Page 33: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 33

Tonsillectomy: special considerations

• Risk for post-operative obstructive apnea

• Risk for post-obstructive pulmonary edema

• Increased risk of bleeding – use of post-operative NSAIDS is controversial as it is associated with increased re-operation.

Anesth Analg 2003;96:68 –77.

Page 34: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 34

Child with cardiac murmur

• Innocent murmur

• Pathologic murmur

• New Endocarditis prophylaxis guidelines

• Cardiology evaluation and f/u for a child with complex congenital heart disease.

Pediatrics 1996;98;502-508.

Current Opinion in Anaesthesiology 2007, 20:216–220

Page 35: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 35

Hypoplastic Left Heart Syndrome and Non-cardiac surgery

J Pediatr Surg. 2002;37:1399-1403.

Page 36: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 36

Prophylaxis against bacterial endocarditis

CLASS IIa• Prophylaxis against infective endocarditis is reasonable

for the following patients at highest risk for adverse outcomes from infective endocarditis who undergo dental procedures that involve manipulation of either gingival tissue or the periapical region of teeth or perforation of the oral mucosa:

• Patients with prosthetic cardiac valves or prosthetic material used for cardiac valve repair. (Level of Evidence: B)

• Patients with previous infective endocarditis. (Level of Evidence: B)

• Patients with CHD. (Level of Evidence: B)

Circulation. 2008;118:887-896.

Page 37: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 37

Prophylaxis against bacterial endocarditis

CLASS IIa• Unrepaired cyanotic CHD, including palliative shunts and

conduits. (Level of Evidence: B)• Completely repaired congenital heart defect repaired

with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure. (Level of Evidence: B)

• Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or

• prosthetic device (both of which inhibit endothelialization). (Level of Evidence: B)

• Cardiac transplant recipients with valve regurgitation due to a structurally abnormal valve. (Level of Evidence: C)

Circulation. 2008;118:887-896.

Page 38: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 38

CLASS III

• Prophylaxis against infective endocarditis is not recommended for nondental procedures:

– transesophageal echocardiogram, EGD, or colonoscopy) in the absence of active infection. (Level of Evidence: B)

Prophylaxis against bacterial endocarditis

Circulation. 2008;118:887-896.

Page 39: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 39

Antibiotic dose for BE prophylaxisSINGLE DOSE 30-60 MIN BEFORE• Amoxicillin p.o. 50 mg/kg• Ampicillin 50 mg/kg IM/IV or Cefazolin or

ceftriaxone 50 mg/kg IM/IV• Allergic to penicillins:

– Cephalexin p.o. 50 mg/kg – Clindamycin 20 mg/kg– Azithromycin or clarithromycin 15 mg/kg– Cefazolin or ceftriaxone - 50 mg/kg IM/IV – Clindamycin 20 mg/kg IM or IV

Circulation. 2008;118:887-896.

Page 40: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 40

Page 41: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 41

Page 42: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 42

Page 43: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 43

Page 44: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 44

Page 45: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 45

Morbid Obese patient

• Overweight: BMI > 85%le

• Obesity: BMI of more than 95%le

• Superobesity: BMI > 99 %le

• Adolescent/Adult: BMI > 40 kg/m2

Current Opinion in Anaesthesiology 2008;21:308–312.

Page 46: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 46

Morbid obesity: medical etiology

• Prader–Willi syndrome

• Laurence–Moon–Biedl syndrome

• Hypercaloric diet (glycogen storage diseases)

• Steroid induced (Hem-Onc, nephrotic syndrome)

• Poor mobility (late stage Duchenne’s)

Current Opinion in Anaesthesiology 2008;21:308–312.

Page 47: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 47

Prader Willi Syndrome

Pediatric Anesthesia 2006 16: 712–722

Page 48: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 48

Morbid obesity: perioperative considerations

• Hypertension and LVH

• Obstructive sleep apnea / hypoventilation

• Diabetes / insulin resistance

• GERD

• NAFLD / NASH

Current Opinion in Anaesthesiology 2008;21:308–312.

Page 49: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 49

• Slipped capital femoral epiphysis

• Blount’s disease

• Cholelithiasis

• Polycystic ovary syndrome

• Idiopathic intracranial hypertension (pseudotumour cerebri)

Morbid obesity: Pediatric perioperative considerations

Current Opinion in Anaesthesiology 2008;21:308–312.

Page 50: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 50

Morbid obesity: Pre-operative examination in children

• History:– symptoms of sleep apnea– tolerance to exercise: breathlessness, asthma;– recent weight loss or gain– medications, including OTC herbs or special mixtures taken to

lose weight which can interfere with anaesthesia or haemostasis.

• e.g. garlic, ginger, etc.• Document BMI in percentile chart.• Pulse-oximetry (SpO2) on room air / Nocturnal SpO2

• Fasting blood glucose• Echocardiography (Hypertensive patient)• Preoperative fasting – similar rules as the nonobese population. • GERD: usual anti-reflux therapy should be administered.

Current Opinion in Anaesthesiology 2008;21:308–312.

Page 51: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 51

Elective surgery in morbid obesity: 2009 AHA guidelines

Circulation. 2009;120:86-95.

Page 52: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 52

Neural tube defects

• Assessment for coexistent congenital anomalies• 90% require CSF diversion • Subsequent surgeries:

– Infection– Malfunction– Outgrowing the shunt hardware

• Associated urogenital and musculoskeletal dysfunction– UTI/VUR/hydronephrosis renal function evaluation– Scoliosis respiratory function evaluation– Lower-extremity abnormalities

• Latex allergy

Pediatrics 1996;98;502-508.

Page 53: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 53

Neuromuscular disorders• Inhalational agents: cerebral vasodilation increase ICP • Ensure patency and proper functioning of CSF shunt• Immediate postop period Impaired airway reflexes

– Document pre-operatively any evidence of brainstem dysfunction (eg, vocal cord paralysis, swallowing dysfunction, or aspiration)

• Increased risk for postoperative weakness postoperative respiratory care and prolonged mechanical ventilation / PP.

• Succinylcholine Hyperkalemia; malignant hyperthermia

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 54: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 54

Epilepsy

• Record type and frequency of seizures• Continue antiepileptic medications on the AM of

surgery• Uncontrolled seizures Neurology evaluation.• Check serum levels of anticonvulsant • Most anticonvulsants have long half-lives, and

the omission of one dose does not decrease the blood level significantly.

• No need to determine anticonvulsant levels if:– seizure-free for 2 years – no adjustment of their anticonvulsant dose

Pediatrics 1996;98;502-508.

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 55: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 55

Epilepsy: perioperative considerations

• Tuberous sclerosis – cardiac rhabodomyomas: obstruction, dysrhythmias– Renal lesions HTN, CKD

• Traditional antiepileptics: P-450 inducers • Topiramate NAG metabolic acidosis • Sodium valproate platelet abnormalities, bleeding• Sodium valproate and Felbamate liver failure• Ketogenic diet avoid lactated Ringers solution• Sevoflurane Epileptogenic potential

Childs Nerv Syst. 2006;22:834–843.

J Anesth. 2006;20:135–137.

Paediatric Anaesthesia 2002;12:700–704.

Page 56: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 56

Phakomatoses: extra-CNS findings• Linear nevus sebaceous of Jadassohn

– Aortic coarctation, PDA, VSD

• Neurofibromatosis– Pheochromocytoma – 5%– Kyphoscoliosis (type 1)

• Sturge Weber – Aortic coarctation

• Von Hippel Lindau– Pheocromocytoma – 10%– RCC – 25%

Paediatric Anaesthesia 2000;10:121–128

Page 57: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 57

Cervical spine instability

• Mucopolysaccharidoses (Hurler’s and Monquio’s syndromes): odontoid hypoplasia

• Rheumatoid arthritis: atlantoaxial instability, subaxial instability, and superior migration of the odontoid process.

• Down syndrome: 15% asymptomatic atlantoaxial instability

• Document pre-operative screening flexion-extension Cervical spine Roentgenograms

• Consider fiberoptic intubation.Pediatrics 1996;98;502-508.

Page 58: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 58

Craniosynostosis

• Multidisciplinary evaluation by a craniofacial team • Monitor for signs of increased intracranial pressure• Nonsyndromic craniosynostosis are usually otherwise

healthy.• Syndromic craniosynostosis can have associated

anomalies:– Crouzon’s or Apert’s syndrome can have very abnormal airway

anatomy fiberoptic intubation.

• Identifying a history of OSA• Apert’s syndrome congenital cardiac defects.

Am J Med Gen. 2005; 45(6):758 - 760.Anesthesiology Clin. 2007;25:465–481

Page 59: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 59

Sickle cell patients

• Heterozygous sickle cell trait generally asymptomatic

• Active sickling conditions (SS, SC, S- thalassemia)– reduce risk of complications by preoperative

transfusions to reduce the total HbS level < 40%.

• Coordination among the pediatrician, hematologist, anesthesiologist, and surgeon is essential.

Fu T. Pediatr Blood Cancer 2005;45:43–47.Marchant WA. Paediatric Anaesthesia 2003;13:473–489

Page 60: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 60

Systemic manifestations of SCD

Fu T. Pediatr Blood Cancer 2005;45:43–47.Marchant WA. Paediatric Anaesthesia 2003;13:473–489

Page 61: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 61

Perioperative management of SCD

• Avoid dehydration – impaired renal concentrating ability. • Deoxygenation – incentive spirometry; SpO2 monitoring• Vascular stasis – maintaining a normal C.O., a normal

blood volume, and BP.• Hypothermia – keeping the patient warm • Acidosis – good hydration, warm• Infection – prophylactic antibiotics• Adequate analgesia, to enable effective physiotherapy

and early ambulation must be emphasized.

Page 62: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 62

Regional anesthesia and SCD• Redistribution of blood flow may lead to an increase in

capillary and venous oxygen tension in the blocked region

• Compensatory vasoconstriction in nonblocked areas leads to a fall in the SvO2.

• Lack of control of ventilation, regional hypoperfusion and venous stasis.

• Cooperative Study of Sickle Cell Disease (N=3765) – 10 y. – 1079 surgeries (N= 717)– Post-op SCD-related complications (painful crisis, ACS, and

CVA) were more frequent in patients who received regional anaesthesia (P=0.058).

Koshy M, et al. Blood 1995; 86: 3676–3684.

Marchant WA. Paediatric Anaesthesia 2003;13:473–489

Page 63: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 63

Transfusion in SCD with General Anesthesia

Conclusions.“Minor or low-risk elective surgical procedures in children with Hb SS may not routinely require pre-operative transfusion”

Fu T. Pediatr Blood Cancer 2005;45:43–47

Page 64: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 64

Adenotonsillectomy and SCD

• Postop. pain, hypoventilation, atelectasis, hypoxia. – Aggressive pulmonary toilet, NIPPV,

bronchodilators and incentive spirometry– HbS < 40%. – Preoperative Transfusion in Sickle Cell

Disease Study Group (N=118) no advantage in aggressive transfusion regimen vs. conservative regime.

Marchant WA. Paediatric Anaesthesia 2003;13:473–489Waldron P. J Ped Hematol Onc 1999; 21:129–135.

Page 65: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 65

Cholecystectomy and SCD

• Laparoscopic approach is preferred

• Avoid emergency surgery– high morbidity

• Conservative pre-operative transfusion– National Preoperative Transfusion Study (N=364)– Aggressive: preop Hb 10 g/dL and HbS< 30%– Conservative: Hb 10 g/dL independent of HbS.

• No difference between groups. Marchant WA. Paediatric Anaesthesia. 2003;13:473–489.

Haberkern CM. Blood. 1997;89(5):1533-1542.

Page 66: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 66

Orthopedic Surgery and SCD

• Aseptic necrosis of the hip occurs in up to 50% of patients.

• Conservative preoperative transfusion – Hb (9-11 g/dL).

• Careful use of tourniquet - stasis, hypoxia and acidosis beneath and distal to the tourniquet cuff favors red cell sickling.

Marchant WA. Paediatric Anaesthesia. 2003;13:473–489

Page 67: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 67

Neurosurgery and SCD• Keep Hct > 30 and HbS < 30%

– Minimize risk of stroke

• Careful use of hypertonic agents– Urea – preferred– Old contrast media

• Careful use of Epsilon-Aminocaproic Acid– Generally used in spinal surgery – Can predispose to vaso-occlusive crises

• Avoid hypothermiaMarchant WA. Paediatric Anaesthesia. 2003;13:473–489

Page 68: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 68

Cardiac Surgery and SCD

• Open-heart surgery with hypothermic cardiopulmonary bypass precipitate sickling.

• Preoperative correction of anemia

• Pre-operative exchange transfusion– Increase in 2,3-DPG increase DO2

• Avoidance of hypoxia and acidosis

• Avoidance of aortic cross-clamping, hypothermia, cardioplegia and topical cooling

Marchant WA. Paediatric Anaesthesia. 2003;13:473–489

Page 69: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 69

Patients on chronic steroids

• Perioperative stress dose of steroids

• Prednisone p.o. 2.5–5 mg/m2 BSA the night before

• Hydrocortisone 50 mg/m2 before anesthetic induction

Maxwell LG. Anesthesiology Clin N Am. 2004;22:27-43

Page 70: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 70

Diabetes mellitus

• Acceptable metabolic control:– No ketonuria– Normal serum electrolytes– HbA1c within target range for age:

• < 5 years: 7 – 9%• 5 – 13 years: 6 – 8.5%• > 13 years: 6 – 8%

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 71: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 71

Insulin half life

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 72: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 72

Insulin correction factor

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 73: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 73

Mixed insulin regime (NPH/Lente)

+

No

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 74: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 74

Lantus insulin regime

No

Yes

No

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 75: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 75

Insulin pump – for surgery < 2h

No

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 76: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 76

Insulin pump Surgery > 2h

No

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 77: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 77

Oral hypoglycemic agents

• Hold on the morning of surgery

No

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 78: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 78

Post-operative DM management

No

Yes

Rhodes ET. Anesth Analg 2005;101:986 –99

Page 79: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 79Pediatric Anesthesia 2008 18: 478–487

Page 80: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 80

Perioperative VTE prophylaxis

Pediatric Anesthesia 2008 18: 478–487

Page 81: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 81

Perioperative VTE prophylaxis

Pediatric Anesthesia 2008 18: 478–487

Page 82: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 82

VTE risk of Surgery

Pediatric Anesthesia 2008 18: 478–487

Page 83: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 83

VTE Risk in the ICU

Pediatric Anesthesia 2008 18: 478–487

Page 84: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 84

• Child 1–2 months – 750 ug/kg s.q. bid.

• Child 2 months–18 years – 500 ug/kg s.q. bid.– Maximum dose 20 mg s.q. bid.

• Adolescents of >40 kg weight– Adult dosing of 40 mg qday

Pediatric Anesthesia 2008;18: 478–487

Page 85: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 85

Psychological preparation of the children for surgery

• 50-75% of patients develop significant anxiety

Anesthesiology Clin N Am. 2005;23: 597- 614

Page 86: Perioperative Evaluation and Treatment in Pediatrics

04/08/23 86

Thank you!